Werthmann, Paul G.; Lederer, Ann-Kathrin; Figura, Hannah Maja et al.
PRIO - a prospective integrative oncology registry: trial protocolFRONTIERS IN ONCOLOGY. Bd. 14. 2024
Renner, Vanessa
Pro- and anti-inflammatory cytokine concentrations and their influence on therapy outcome in female patients with post-traumatic stress disorderPSYCHONEUROENDOCRINOLOGY. Bd. 160. 2024
Grundmann, D.; Rudolph, T.; Adam, M. et al.
Procedural and clinical outcomes according to ultrasound-guided access in TAVI: a propensity-matched comparative sub-analysis from the PULSE registryEUROPEAN HEART JOURNAL. Bd. 45. 2024
Frey, Marie-Luise; Morsbach, Svenja; Domogalla, Matthias et al.
Process Control of Multistep Surface Functionalization on Hydroxyethyl Starch Nanocapsules Determines the Reproducibility of the Biological EfficacyBIOMACROMOLECULES. Bd. 25. H. 11. 2024 S. 7108-7122
Klimek, Ludger; Chaker, Adam; Hox, Valerie et al.
Professor Peter Valentin Tomazic, Graz, AustriaALLERGY. Bd. 79. H. 8. 2024 S. 2311-2312
Krajewski, Piotr K.; Strobel, Alexandra; Schultheis, Michael et al.
Profound Sexual Dysfunction Among Patients with Hidradenitis Suppurativa: A Cross-sectional StudyDERMATOLOGY AND THERAPY. Bd. 14. H. 7. 2024 S. 1823-1838
Stute, Petra; Walker, Linus Josef; Eicher, Astrid et al.
Progestogens for endometrial protection in combined menopausal hormone therapy: A systematic reviewBEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM. Bd. 38. H. 1. 2024
Heimes, Anne-Sophie; Shehaj, Ina; Almstedt, Katrin et al.
Prognostic Impact of Acute and Chronic Inflammatory Interleukin Signatures in the Tumor Microenvironment of Early Breast CancerINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 25. H. 20. 2024
Shehaj, Ina; Krajnak, Slavomir; Rad, Morva Tahmasbi et al.
Prognostic impact of metabolic syndrome in patients with primary endometrial cancer: a retrospective bicentric studyJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. Bd. 150. H. 4. 2024
Fasching, Peter A.; Hack, Carolin C.; Nabieva, Naiba et al.
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/ HER2neg breast cancer patients treated with upfront letrozoleEUROPEAN JOURNAL OF CANCER. Bd. 209. 2024